Jenburkt Pharmaceuticals Ltd

Jenburkt Pharmaceuticals is a speciality pharmaceutical formulation Company engaged in the development, manufacture and marketing of quality finished dosages.(Source : 201903 Annual Report Page No: 08)

Pros:
Company is virtually debt free.
Company has good consistent profit growth of 21.45% over 5 years
Company has a good return on equity (ROE) track record: 3 Years ROE 28.89%
Company has been maintaining a healthy dividend payout of 22.51%
Cons:
The company has delivered a poor growth of 9.98% over past five years.
Debtor days have increased from 46.70 to 68.13 days

Peer Comparison Sector: Pharmaceuticals // Industry: Pharmaceuticals - Indian - Formulations

Loading peers table ...

Quarterly Results Figures in Rs. Crores

Sep 2016 Dec 2016 Mar 2017 Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019
28.69 24.91 27.40 16.99 36.75 30.87 30.06 23.26 31.98 32.28 35.13 20.84
21.76 20.54 21.71 20.56 24.35 24.41 21.55 20.66 24.90 25.91 26.22 21.46
Operating Profit 6.93 4.37 5.69 -3.57 12.40 6.46 8.51 2.60 7.08 6.37 8.91 -0.62
OPM % 24.15% 17.54% 20.77% -21.01% 33.74% 20.93% 28.31% 11.18% 22.14% 19.73% 25.36% -2.98%
Other Income 0.63 0.66 0.89 1.11 0.94 0.69 0.65 0.91 0.90 0.67 0.93 1.24
Interest 0.11 0.09 0.13 0.09 0.09 0.11 0.13 0.09 0.09 0.11 0.10 0.07
Depreciation 0.45 0.45 0.45 0.36 0.38 0.38 0.38 0.32 0.33 0.35 0.35 0.53
Profit before tax 7.00 4.49 6.00 -2.91 12.87 6.66 8.65 3.10 7.56 6.58 9.39 0.02
Tax % 27.71% 34.08% 41.00% 1.03% 22.53% 31.83% 35.49% 12.90% 24.07% 32.07% 26.62% -200.00%
Net Profit 5.06 2.95 3.53 -2.88 9.97 4.54 5.58 2.70 5.74 4.46 6.89 0.06
EPS in Rs 11.20 6.35 7.60 -6.19 21.45 9.89 12.15 5.88 12.52 9.72 15.02 0.13
Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes

Profit & Loss Figures in Rs. Crores

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 TTM
38.39 42.41 51.40 56.91 59.82 69.35 76.22 85.21 93.58 103.31 114.67 122.64 120.23
34.99 38.40 44.95 46.69 50.26 59.44 64.70 69.95 77.12 83.59 90.88 97.64 98.49
Operating Profit 3.40 4.01 6.45 10.22 9.56 9.91 11.52 15.26 16.46 19.72 23.79 25.00 21.74
OPM % 8.86% 9.46% 12.55% 17.96% 15.98% 14.29% 15.11% 17.91% 17.59% 19.09% 20.75% 20.38% 18.08%
Other Income 0.43 0.50 0.68 0.41 0.82 1.34 1.63 2.10 2.74 2.96 3.39 3.38 3.74
Interest 1.04 0.94 0.58 0.55 0.63 0.94 1.27 0.36 0.38 0.41 0.41 0.39 0.37
Depreciation 0.64 0.67 0.82 0.99 1.22 1.48 1.55 2.66 1.99 1.79 1.50 1.35 1.56
Profit before tax 2.15 2.90 5.73 9.09 8.53 8.83 10.33 14.34 16.83 20.48 25.27 26.64 23.55
Tax % 39.53% 43.79% 34.03% 33.77% 29.66% 29.56% 27.30% 32.78% 35.95% 34.03% 31.86% 25.64%
Net Profit 1.30 1.63 3.78 6.02 6.00 6.22 7.51 9.65 10.78 13.51 17.21 19.80 17.15
EPS in Rs 2.58 3.20 7.61 12.37 12.30 12.69 15.32 19.47 21.72 29.05 37.50 43.14 37.39
Dividend Payout % 44.71% 51.35% 36.90% 27.03% 27.13% 31.40% 31.58% 30.36% 31.06% 27.88% 16.00% 23.65%
* Sales is net of excise duty and discounts
Compounded Sales Growth
10 Years:11.20%
5 Years:9.98%
3 Years:9.43%
TTM:-0.59%
Compounded Profit Growth
10 Years:28.30%
5 Years:21.45%
3 Years:22.51%
TTM:-24.75%
Stock Price CAGR
10 Years:27.93%
5 Years:6.54%
3 Years:3.80%
1 Year:-38.87%
Return on Equity
10 Years:30.79%
5 Years:29.31%
3 Years:28.89%
Last Year:28.57%

Balance Sheet Figures in Rs. Crores

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
4.65 4.65 4.65 4.65 4.65 4.65 4.65 4.65 4.65 4.65 4.59 4.59
Reserves 3.16 3.60 5.68 9.91 14.05 18.00 22.66 28.79 35.54 49.79 56.67 72.88
Borrowings 9.53 6.95 4.87 2.18 2.38 4.64 2.04 6.63 5.42 6.37 0.25 7.47
8.22 10.60 11.43 19.11 19.28 21.71 14.59 20.77 12.55 15.72 16.35 18.00
Total Liabilities 25.56 25.80 26.63 35.85 40.36 49.00 43.94 60.84 58.16 76.53 77.86 102.94
6.09 6.45 7.36 10.27 13.11 14.23 13.57 11.60 12.11 10.63 9.57 9.59
CWIP 0.00 0.97 1.05 0.52 0.24 0.00 0.00 0.00 0.00 0.00 0.00 0.99
Investments 0.39 0.48 0.57 0.79 0.53 0.31 0.31 0.31 0.61 1.94 5.42 5.38
19.08 17.90 17.65 24.27 26.48 34.46 30.06 48.93 45.44 63.96 62.87 86.98
Total Assets 25.56 25.80 26.63 35.85 40.36 49.00 43.94 60.84 58.16 76.53 77.86 102.94

Cash Flows Figures in Rs. Crores

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
0.53 4.43 4.74 7.33 6.92 4.54 11.43 8.69 7.82 9.95 16.18 12.99
-0.18 -0.97 -0.59 -3.22 -2.84 -1.14 0.44 1.24 -0.27 -9.77 1.00 -10.53
-0.15 -3.55 -3.71 -2.19 -1.66 0.08 -6.53 0.83 -5.42 0.68 -17.98 -2.42
Net Cash Flow 0.20 -0.09 0.44 1.92 2.42 3.48 5.34 10.76 2.13 0.86 -0.80 0.04

Ratios Figures in Rs. Crores

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
ROCE % 18.53% 23.72% 41.58% 60.43% 47.91% 40.36% 40.89% 42.26% 40.15% 39.03% 41.91% 36.95%
Debtor Days 47.63 31.41 27.48 30.53 22.45 31.68 26.24 31.61 22.54 32.04 39.92 68.13
Inventory Turnover 5.44 6.11 8.21 10.09 9.90 9.91 10.72 12.10 11.83 10.88 13.07 14.75

Recent Announcements

View all announcements

Annual Reports

Credit Ratings